Primary Care Enhanced Services

In a recent procurement process overseen by the NHS Lincolnshire Integrated Care Board, an intention to award notice was made public for the provision of Primary Care Enhanced Services, covering various facets such as Phlebotomy, Warfarin, and Safeguarding. This procurement is under the Provider Selection Regime, specifically the Health Care Services Regulations 2023, excluding the Public Contracts Regulations 2015 and Procurement Act 2023. The associated procurement stage is at the 'Award' phase, and the notice marks the beginning of a standstill period, allowing providers to make representations by 12th September 2025.

This contract, valued at £79,034 and facilitated through a limited procurement method, is anticipated to run from 1st April 2025 to 31st March 2026, serving the UKF3 region. This tender presents substantial opportunities for businesses, particularly those within the healthcare services sector, to collaborate with the NHS and reinforce service delivery in the region. With the procurement focusing on maintaining high standards of quality and innovation, as well as social value and service sustainability, companies proficient in these areas are well-suited to engage with the contract.

The existing and potential suppliers, such as small and medium enterprises (SMEs), could leverage this procurement to expand their service offerings in general-practitioner services. The engagement in primary care services could further enhance a supplier’s reputation and contribute to tackling health inequalities within the community.